Completed Infection & Immunity Genetics & Molecular Biology

Infection response through virus genomics

In plain English

AI plain-English summary

Every year, viruses cost the NHS millions in treatment and lost productivity, yet hospitals cannot routinely read the full genetic code of the viruses infecting their patients. This gap means doctors often lack the detailed information needed to spot drug-resistant strains, trace how a norovirus outbreak spreads through a ward, or detect the early signs of a measles epidemic in the community. Professor Deenan Pillay and his team at University College London are building next-generation sequencing technology to capture complete viral genomes directly from clinical samples. They aim to develop reliable methods for preparing samples, run real-time full-length virus sequencing, and deliver the resulting data to NHS clinicians in a format that directly informs patient care and infection control. If successful, this work could transform how the NHS treats HIV and hepatitis C infections by tailoring drugs to each patient’s viral strain. It would also allow hospitals to track norovirus transmission with precision, and give public health teams the tools to monitor and contain community outbreaks of measles and influenza far more effectively than current surveillance allows.

View original technical description
Viruses are a major cause of morbidity and mortality, with a high cost to the NHS. Viruses have significant genomic variation, which underpins pathogenicity, drug resistance, and transmission. Despite enormous advances in technology, we currently lack the systems, facilities and capacity to routinely capture full-length viral gene sequences, to monitor drug resistance at the granularity to optimally guide treatment, to identify the source of viral transmissions within healthcare settings, and to track emerging epidemics. Professor Deenan Pillay of University College Lomndon and collaborators are developing next generation sequencing technology to capture virus genomes from clinical samples. The team’s goals are to i) deploy optimal methods for preparing clinical and surveillance isolates for sequencing, ii) develop robust and reliable real time full length virus sequencing, iii) deliver data to NHS users in a form suited to inform direct clinical care, hospital control, and intervention in epidemics. It is hoped that the technology will lead to more effective treatment of HIV and HCV infections, more targeted hospital infection control regarding norovirus infections, and better dynamic assessment and targeted management of community based viral outbreaks, in particular measles and influenza.

View the original record at the funder ↗

Related Research

Grants with similar aims, by meaning.

InfeCtion respONse through vIrus genomiCs (ICONIC)
Putting genomic surveillance at the heart of viral epidemic response.
Modernising medical microbiology: Establishing how new technologies can be optimally integrated into microbiology
Respiratory virus and microbiome initiative
Understanding the evolution and diversity of viral pathogens using next generation sequencing technologies

Original classification

Research

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.